Multiple myeloma (MM) is an incurable blood cancer, leading to weakened immunity, bone damage, and other serious health ...

Multiple Myeloma (MM) is an incurable blood cancer, leading to weakened immunity, bone damage, and other serious health ...

4, 2024 — A new study shows strong alignment between real-world outcomes and those seen in clinical trials among a broad population of patients with relapsed or refractory multiple myeloma.

Our additional preliminary studies demonstrate that dual targeting of multiple myeloma cells and BM-CAFs by CAR-T cells is ...

After a while, the color of the population whose genetic ... of different cell populations is especially important in ...

Multiple myeloma is a kind of blood cancer that starts in white blood cells called plasma cells. Cancerous plasma cells grow out of control in your bone marrow, so there’s not enough room for ...

Braunstein, MD, PhD, FACP, and hematology/oncology fellow Olivia Main, MD, talk about their choices for a patient with ...

GSK is carving out a niche for Blenrep in the second-line multiple myeloma setting, for which it projects multi-blockbuster ...

Hamlet Gasoyan, MD, discussed the implications of a multiple myeloma study’s findings and their potential impact on clinical ...

Your physician will also find out the stage of your cancer. To stage multiple myeloma, we need to see how far along your disease is. Your physician will use blood tests and a bone marrow biopsy to ...